COVID-19 Antibody Testing of Recipients of Solid Organ Transplants and Patients with Chronic Diseases
COVID-19 Antibody Testing of Recipients of Solid Organ Transplants and Patients with Chronic Diseases is being led by a team of researchers at Johns Hopkins Medicine. The principal investigator is William Werbel, MD. The study has been approved by the Johns Hopkins Institutional Review Board (IRB00248540).
The purpose of this research study is to determine COVID-19 antibody levels in patients with chronic conditions who receive the COVID-19 vaccine. The study does not provide the vaccine, and study team members will not be offering guidance as to whether one should or should not receive the SARS-CoV-2 vaccine. If participants will be receiving a vaccine and are interested in the study, we will collect a sample before vaccination, and collect samples at sequential time points post-vaccination to determine antibody levels.
Thank you for your interest in our study of COVID-19 Antibody Testing of Recipients of Solid Organ Transplants and Patients with Chronic Diseases. Due to an overwhelming interest in out study, we have reached capacity and have closed enrollment at this time.
Dorry Segev, MD, PhD | William Werbel, MD | Julie Paik, MD | Lisa Christopher-Stine, MD | Robin Avery, MD | Douglas Mogul, MD, PhD | Jacqueline Garonzik-Wang, MD, PhD | Brian Boyarsky, MD | Caoilfhionn Connolly, MD | Jonathan Mitchell, MBBS |
Jennifer Alejo, MD
Copyright Johns Hopkins University, 2020 | Baltimore, MD 21205
COVID-19 Vaccination in Patients with Chronic Conditions